Open-label, Single Arm, Interventional Study to Explore the Efficacy and Safety of Paliperidone ER in the Management of Patients With Acute Agitation and/or Aggression.

Trial Profile

Open-label, Single Arm, Interventional Study to Explore the Efficacy and Safety of Paliperidone ER in the Management of Patients With Acute Agitation and/or Aggression.

Completed
Phase of Trial: Phase IV

Latest Information Update: 18 Feb 2016

At a glance

  • Drugs Paliperidone (Primary) ; Benzodiazepines
  • Indications Aggression; Agitation
  • Focus Therapeutic Use
  • Acronyms IMPACT
  • Sponsors Janssen-Cilag
  • Most Recent Events

    • 20 Dec 2012 Actual initiation date changed from 1 Jan 2010 to 1 Mar 2010 as reported by ClinicalTrials.gov record.
    • 19 Mar 2012 Actual patient number (56) added as reported by ClinicalTrials.gov.
    • 19 Mar 2012 Actual end date (Dec 2011) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top